Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review Luis Gutiérrez-Rojas; Jesús José de la Gándara Martín; Luisa García Buey; Juan I. Uriz Otano; Álvaro Mena; Carlos Roncero;

Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years Rafael Esteban; Raquel Domínguez-Hernández; Helena Cantero; Miguel Ángel Casado;

Acute hepatitis due to the hepatitis C virus: Where are the transmission occurring? Rita Desirée Pérez Jiménez; Rafael Granados Monzón; Melisa Hernández Febles; María José Pena López;